US biotech seems reenergized, but unsettled policy questions take a back seat to pending national elections, particularly with the presidency at stake. Jeffrey L Fox reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fox, J.L. Nat. Biotechnol. 29, 303–305 (2011).
Anonymous. Nat. Biotechnol. 30, 198 (2012).
Fox, J.L. Nat. Biotechnol. 29, 953–954 (2011).
Fox, J.L. Nat. Biotechnol. 29, 1062 (2011).
Mullard, A. Nat. Rev. Drug Discov. 11, 91–94 (2012).
Fox, J.L. Nat. Biotechnol. 28, 1141–1142 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Positive signals from Washington. Nat Biotechnol 30, 306–308 (2012). https://doi.org/10.1038/nbt.2175
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2175
